VASCULAR SOLUTIONS INC
S-1/A, EX-27.1, 2000-06-26
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: VASCULAR SOLUTIONS INC, S-1/A, EX-24.1, 2000-06-26
Next: FIRSTENERGY CORP, 11-K, 2000-06-26



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS AS OF AND FOR THE THREE MONTHS ENDED MARCH 31, 2000 AND AS
OF AND FOR THE YEAR ENDED DECEMBER 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   YEAR
<FISCAL-YEAR-END>                          MAR-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               MAR-31-2000             DEC-31-1999
<CASH>                                       8,064,673              10,529,191
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  602,069                 374,978
<ALLOWANCES>                                         0                       0
<INVENTORY>                                    854,302                 612,569
<CURRENT-ASSETS>                             9,616,967              11,609,915
<PP&E>                                         762,725                 684,952
<DEPRECIATION>                                 491,146                 410,422
<TOTAL-ASSETS>                              10,379,692              12,294,867
<CURRENT-LIABILITIES>                        1,098,103               1,122,669
<BONDS>                                              0                       0
                           37,778                  37,778
                                          0                       0
<COMMON>                                        52,651                  52,503
<OTHER-SE>                                    (72,619)                (90,931)
<TOTAL-LIABILITY-AND-EQUITY>                 9,281,589              11,172,198
<SALES>                                        642,545               1,429,094
<TOTAL-REVENUES>                               642,545               1,429,094
<CGS>                                          348,851               1,065,199
<TOTAL-COSTS>                                2,346,514               8,597,418
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                            (1,931,121)             (7,862,457)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (1,931,121)             (7,862,457)
<EPS-BASIC>                                      (.37)                  (1.95)
<EPS-DILUTED>                                    (.21)                  (1.01)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission